The pharmaceutical industry is continually seeking innovative therapies for chronic diseases. Among these breakthroughs, FDA-Registered Peptides have emerged as a potential strategy. , Particularly Apis, Liraglutide, https://zoewiqh362507.articlesblogger.com/59225317/fda-approved-peptides-apis-liraglutide-tirzepatide-semaglutide